NO20080461L - Solvat av kabergolin og preparater av kobergolin form I - Google Patents

Solvat av kabergolin og preparater av kobergolin form I

Info

Publication number
NO20080461L
NO20080461L NO20080461A NO20080461A NO20080461L NO 20080461 L NO20080461 L NO 20080461L NO 20080461 A NO20080461 A NO 20080461A NO 20080461 A NO20080461 A NO 20080461A NO 20080461 L NO20080461 L NO 20080461L
Authority
NO
Norway
Prior art keywords
cabergoline
cobergoline
preparations
solvent
solvate
Prior art date
Application number
NO20080461A
Other languages
English (en)
Inventor
Parveen Bhatarah
Alan Greenwood
Derek Mchattie
Mahmoud Aloui
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of NO20080461L publication Critical patent/NO20080461L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Abstract

Fremgangsmåte for fremstilling av kabergolin Form I, som omfatter å danne et solvat inkluderende kabergolin og et p-disubstituert benzen med formel (A) og å oppnå kabergolin Form I fra solvatet. Et annet aspekt av den foreliggende oppfinnelse tilveiebringer en fremgangsmåte for fremstilling av kabergolin Form I som omfatter å oppløse kabergolin i p-disubstituert benzen og å utvinne kabergolin Form I poly-lomorfen, passende ved direkte krystallisering av Form I eller ved utvinning av et solvat som kan omdannes til Form I.
NO20080461A 2005-07-27 2008-01-24 Solvat av kabergolin og preparater av kobergolin form I NO20080461L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0515430.7A GB0515430D0 (en) 2005-07-27 2005-07-27 Preparation of cabergoline
PCT/GB2006/002784 WO2007012846A1 (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline form i

Publications (1)

Publication Number Publication Date
NO20080461L true NO20080461L (no) 2008-04-18

Family

ID=34976701

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080461A NO20080461L (no) 2005-07-27 2008-01-24 Solvat av kabergolin og preparater av kobergolin form I

Country Status (10)

Country Link
EP (1) EP1912984A1 (no)
JP (1) JP2009502895A (no)
CN (1) CN101228159A (no)
AU (1) AU2006273831A1 (no)
CA (1) CA2616738A1 (no)
GB (1) GB0515430D0 (no)
IL (1) IL188598A0 (no)
NO (1) NO20080461L (no)
WO (1) WO2007012846A1 (no)
ZA (1) ZA200801151B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
CN104147041B (zh) * 2014-08-17 2017-02-22 山西振东安特生物制药有限公司 一种含胶体果胶铋的分散制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
AU2003224665A1 (en) * 2002-03-15 2003-09-29 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
BR0308304A (pt) * 2002-03-15 2004-12-28 Pharmacia Corp Processo para preparar forma i cristalina de cabergolina
WO2004101510A2 (en) * 2003-05-08 2004-11-25 Ivax Corporation Polymorphs of cabergoline

Also Published As

Publication number Publication date
GB0515430D0 (en) 2005-08-31
JP2009502895A (ja) 2009-01-29
EP1912984A1 (en) 2008-04-23
CA2616738A1 (en) 2007-02-01
WO2007012846A1 (en) 2007-02-01
CN101228159A (zh) 2008-07-23
ZA200801151B (en) 2009-04-29
AU2006273831A1 (en) 2007-02-01
IL188598A0 (en) 2008-04-13

Similar Documents

Publication Publication Date Title
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
NO20084278L (no) Bezothiazol derivatives as beta2 adrenoreceptor agonists
NO20082909L (no) Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene
NO20092960L (no) Krystallinsk minocycline base og framgangsmater for framstilling av denne
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
NO20075299L (no) Hydrogenated benzo (c) thiophene derivatives as immunomodulators
NO20080879L (no) HCV-NS3-proteaseinhibitorer
TW200612948A (en) 2-substituted heteroaryl compounds
EA200701462A1 (ru) Распадающаяся при пероральном приёме композиция оланзапина или донепезила
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20091599L (no) Kjemiske forbindelser
NO20085417L (no) Krystallinske former av 11beta-(4-acetylfenyl)-20,20,21,21,21-pentafluor-17-hydroksy-19-nor-17alfa-pregna-4,9-dien-3-on
NO20085004L (no) Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler
NO20082805L (no) Bicykliske cinnamidforbindelser
NO20055688L (no) Organiske forbindelser
TW200714586A (en) Crystalline forms of a biphenyl compound
NO20090327L (no) Nye forbindelser 384
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
UA102787C2 (ru) Способ приготовления кристаллических форм а и в илапразола и способ преобразования кристаллических форм
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
BR112013000448A2 (pt) Método para produzir uma composição de fase orgânica para uso na extração com solvente de metais de terras raras da fase aquosa
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
WO2009138847A3 (en) An improved process for the preparation of cefozopran
NO20085359L (no) Fremgangsmate for fremstilling av renset hydrokinon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application